[Chemotherapy of myasthenia].
D018908:Muscle Weakness; D009157:Myasthenia Gravis / Q000628:therapy*; D009388:Neostigmine / Q000627:therapeutic use*
D009388:Neostigmine
MYASTHENIA GRAVIS/therapy; NEOSTIGMINE/therapeutic use
Arch Int Pharmacodyn Ther. 1949 Jul;80(1):62-8
18133056
J Am Med Assoc. 1949 Sep 10;141(2):107-11
18138516
J Am Med Assoc. 1952 Feb 16;148(7):508-13
14888515
Neurology. 1951 Mar-Apr;1(2):145-52
14827066
Arch Int Pharmacodyn Ther. 1951 Feb;85(3-4):288-305
14830345
AMA Arch Neurol Psychiatry. 1951 Aug;66(2):163-70
14846441
Br J Pharmacol Chemother. 1949 Mar;4(1):29-32
18113150
Br J Pharmacol Chemother. 1946 Mar;1:38-61
20999334
Arch Int Pharmacodyn Ther. 1950 Aug 1;83(3):452-63
15426408
Br J Pharmacol Chemother. 1950 Mar;5(1):37-48
15405467
Zur medikamentösen Behandlung der Myasthenie.